Challenges in developing personalized neoantigen cancer vaccines

Area of Science:

• Oncology
• Immunology
• Vaccinology

Background:

• Cancer immunotherapies leverage the immune system for treatment.
• Neoantigen vaccines aim to target tumors specifically, sparing healthy tissue.
• Extensive research and numerous clinical trials have explored neoantigen vaccine strategies.

Purpose of the Study:

• To review the key obstacles hindering the efficacy of neoantigen vaccines in cancer therapy.
• To identify challenges in vaccine design and the tumor microenvironment.
• To explore strategies for realizing the full potential of neoantigen vaccines.

Main Methods:

• Review of preclinical research and clinical trial data.
• Analysis of vaccine design principles.
• Examination of the tumor microenvironment's impact on immunotherapy.

Main Results:

• Despite significant research, definitive clinical efficacy for neoantigen vaccines remains elusive for most trials.
• Obstacles exist in both the design of effective vaccine formulations and overcoming the immunosuppressive tumor microenvironment.
• The potential of neoantigen vaccines is currently limited by these unresolved challenges.

Conclusions:

• Unleashing the therapeutic potential of neoantigen vaccines requires addressing critical barriers in vaccine design.
• Overcoming the complexities of the tumor microenvironment is essential for successful cancer immunotherapy.
• Further research is needed to optimize neoantigen vaccine strategies for improved clinical outcomes.